Page last updated: 2024-08-24

plerixafor and Focal Segmental Glomerulosclerosis

plerixafor has been researched along with Focal Segmental Glomerulosclerosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Advani, A; Advani, SL; Chen, LH; Connelly, KA; Gibson, IW; Gilbert, RE; Kabir, MG; Kelly, DJ; Marsden, PA; Sood, MM; Thai, K; Yuen, DA1

Other Studies

1 other study(ies) available for plerixafor and Focal Segmental Glomerulosclerosis

ArticleYear
SDF-1/CXCR4 signaling preserves microvascular integrity and renal function in chronic kidney disease.
    PloS one, 2014, Volume: 9, Issue:3

    Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzylamines; Biopsy; Capillaries; Cell Line; Chemokine CXCL12; Cyclams; Fibrosis; Glomerulosclerosis, Focal Segmental; Heterocyclic Compounds; Humans; Immunohistochemistry; Kidney; Kidney Function Tests; Nephrectomy; Nitric Oxide Synthase Type III; Perindopril; Phosphorylation; Rats; Rats, Inbred F344; Real-Time Polymerase Chain Reaction; Receptors, CXCR4; Renal Insufficiency, Chronic; RNA, Messenger; Serine; Signal Transduction

2014